Opinion|Videos|June 24, 2024

Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy

Author(s)David I. Lee, MD, FACS, Firas F. Abdollah, MD, Evan Kovac, MD

The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.

Episodes in this series

A panel of 4 experts on prostate cancer

EP. 1 The Role of Imaging in Diagnosing and Staging Prostate Cancer

A panel of 4 experts on prostate cancer

EP. 2 Advances in Prostate Biopsy

A panel of 4 experts on prostate cancer

EP. 3 Benefits of Incorporating Fusion-Guided Biopsy into Practice

A panel of 4 experts on prostate cancer

EP. 4 A Review of the Data for Fusion-Based Biopsy Procedures

A panel of 4 experts on prostate cancer

EP. 5 Understanding Differences in Fusion-Guided Biopsy Technologies

A panel of 4 experts on prostate cancer

EP. 6 The Role for Systematic Biopsy Plus MRI-Targeted Procedures

A panel of 4 experts on prostate cancer

EP. 7 Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer

A panel of 4 experts on prostate cancer

EP. 8 Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy

A panel of 4 experts on prostate cancer

EP. 9 Incorporating Fusion-Guided Biopsy to Practice

A panel of 4 experts on prostate cancer

EP. 10 Future Directions for Imaging and Biopsy in Prostate Cancer

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 11 The Impact of MRI-Guided Biopsy in Diagnosis and Treatment Decisions

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 12 Overcoming Limitations of Traditional Biopsies with MRI-Guided Biopsies

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 13 An Overview of Fusion-Guided Systems

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 14 Fusion-Based Biopsies in Active Surveillance

EP. 15 Expert Insights on MRI-US Fusion-Guided Biopsy

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 16 The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer

Kyrollis Attalla, MD, an expert on prostate cancer

EP. 17 Looking Ahead: Image-Guided Diagnostic Tools

Video content above is prompted by the following questions:

What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

ByLorelei A. Mucci, ScD, MPH

September 11th 2026

Doublet or triplet? Urologists weighs in on mCSPC options

ByUrology Times staff

September 10th 2026

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 10th 2026

App-based intervention aims to increase PSA screening among Black men

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

Prior auth, step therapy, and consolidation pressure: Independent urology's challenge